Published ahead of print on January 30, 2004, doi:10.1165/rcmb.2003-0287OC
Am. J. Respir. Cell Mol. Biol., Volume 30, Number 6, June 2004, 908-913
A more recent version of this article appeared on June 1, 2004
Submitted on July 31, 2003
Revised on January 30, 2004
Hypoxia Decreases Soluble Guanylate Cyclase Expression in Pulmonary Artery Smooth Muscle Cells
Paul M Hassoun1*, Galina Filippov2, Michael Fogel3, Cameron Donaldson3, Usamah S Kayyali3, Larissa A Shimoda1, and Kenneth D Bloch2
1 Medicine, Johns Hopkins, Baltimore, Maryland, USA,
2 Medicine, Massachusetts General Hospital, Boston, Massachussets, USA,
3 Medicine, Tufts University School of Medicine, Boston, Massachussets, USA
* To whom correspondence should be addressed. E-mail: phassoun{at}jhmi.edu.
Nitric oxide (NO) has an important role in modulating the pulmonary vascular tone. NO acts, in part, by stimulating soluble guanylate cyclase (sGC) to synthesize the intracellular second messenger cGMP. In vascular smooth muscle cells, sGC is a heterodimer composed of 1 and 1 subunits. The objective of this study was to test whether oxygen concentration regulates sGC expression in cultured rat pulmonary artery smooth muscle cells (rPaSMC). rPaSMC were exposed to 0, 3, and 20% oxygen for 1 to 48 hours, and sGC subunit mRNA levels were measured. Compared with rPaSMC exposed to 20% oxygen, sGC 1 and 1 subunit mRNA levels were markedly decreased in rPaSMC exposed to 0% and 3% oxygen. The decrease in sGC subunit mRNA levels in hypoxic rPaSMC was detected as early as 6 hours of exposure. Compared with rPaSMC exposed to 20% oxygen, exposure of rPaSMC to 3% oxygen progressively decreased sGC subunit protein levels at 24 and 48 hours. There was also a 30% and 50% decrease in sGC enzyme activity in cells exposed to hypoxia for 24 and 48 hours (P <0.05 and P <0.001, respectively, as compared to cells maintained in normoxia). These results demonstrate that hypoxia decreases sGC expression in cultured pulmonary artery smooth muscle cells and suggest that, in hypoxic vascular smooth muscle, decreased cGMP synthesis may limit the vasodilator response to NO.
This article has been cited by other articles:

|
 |

|
 |
 
M. L. Marro, C. Peiro, C. M. Panayiotou, R. S. Baliga, S. Meurer, H. H. H. W. Schmidt, and A. J. Hobbs
Characterization of the Human {alpha}1{beta}1 Soluble Guanylyl Cyclase Promoter: KEY ROLE FOR NF-{kappa}B(p50) AND CCAAT-BINDING FACTORS IN REGULATING EXPRESSION OF THE NITRIC OXIDE RECEPTOR
J. Biol. Chem.,
July 18, 2008;
283(29):
20027 - 20036.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Q. Xue, C. A. Ducsay, L. D. Longo, and L. Zhang
Effect of long-term high-altitude hypoxia on fetal pulmonary vascular contractility
J Appl Physiol,
June 1, 2008;
104(6):
1786 - 1792.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Mingone, M. Ahmad, S. A. Gupte, J. L. Chow, and M. S. Wolin
Heme oxygenase-1 induction depletes heme and attenuates pulmonary artery relaxation and guanylate cyclase activation by nitric oxide
Am J Physiol Heart Circ Physiol,
March 1, 2008;
294(3):
H1244 - H1250.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. He, J. Chen, X. Liu, B. Dinger, and S. Fidone
Enhanced nitric oxide-mediated chemoreceptor inhibition and altered cyclic GMP signaling in rat carotid body following chronic hypoxia
Am J Physiol Lung Cell Mol Physiol,
December 1, 2007;
293(6):
L1463 - L1468.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. P. Coggins and K. D. Bloch
Nitric Oxide in the Pulmonary Vasculature
Arterioscler. Thromb. Vasc. Biol.,
September 1, 2007;
27(9):
1877 - 1885.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Oka, V. Karoor, N. Homma, T. Nagaoka, E. Sakao, S. M. Golembeski, J. Limbird, M. Imamura, S. A. Gebb, K. A. Fagan, et al.
Dehydroepiandrosterone upregulates soluble guanylate cyclase and inhibits hypoxic pulmonary hypertension
Cardiovasc Res,
June 1, 2007;
74(3):
377 - 387.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Mingone, S. A. Gupte, J. L. Chow, M. Ahmad, N. G. Abraham, and M. S. Wolin
Protoporphyrin IX generation from {delta}-aminolevulinic acid elicits pulmonary artery relaxation and soluble guanylate cyclase activation.
Am J Physiol Lung Cell Mol Physiol,
September 1, 2006;
291(3):
L337 - L344.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. M. Williams, C. R. White, M. M. Chang, E. R. Injeti, L. Zhang, and W. J. Pearce
Chronic hypoxic decreases in soluble guanylate cyclase protein and enzyme activity are age dependent in fetal and adult ovine carotid arteries
J Appl Physiol,
June 1, 2006;
100(6):
1857 - 1866.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. J. Mingone, S. A. Gupte, N. Ali, R. A. Oeckler, and M. S. Wolin
Thiol oxidation inhibits nitric oxide-mediated pulmonary artery relaxation and guanylate cyclase stimulation
Am J Physiol Lung Cell Mol Physiol,
March 1, 2006;
290(3):
L549 - L557.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
R. Dumitrascu, N. Weissmann, H. A. Ghofrani, E. Dony, K. Beuerlein, H. Schmidt, J.-P. Stasch, M. J. Gnoth, W. Seeger, F. Grimminger, et al.
Activation of Soluble Guanylate Cyclase Reverses Experimental Pulmonary Hypertension and Vascular Remodeling
Circulation,
January 17, 2006;
113(2):
286 - 295.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2004 American Thoracic Society.
|
|
|